DE3584370D1 - Verwendung von podophyllotoxin und dessen derivaten. - Google Patents

Verwendung von podophyllotoxin und dessen derivaten.

Info

Publication number
DE3584370D1
DE3584370D1 DE8686900345T DE3584370T DE3584370D1 DE 3584370 D1 DE3584370 D1 DE 3584370D1 DE 8686900345 T DE8686900345 T DE 8686900345T DE 3584370 T DE3584370 T DE 3584370T DE 3584370 D1 DE3584370 D1 DE 3584370D1
Authority
DE
Germany
Prior art keywords
podophyllotoxin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686900345T
Other languages
English (en)
Inventor
Boerje Rosen
Kurt Leander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conpharm AB
Original Assignee
Conpharm AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conpharm AB filed Critical Conpharm AB
Application granted granted Critical
Publication of DE3584370D1 publication Critical patent/DE3584370D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE8686900345T 1984-12-28 1985-12-20 Verwendung von podophyllotoxin und dessen derivaten. Expired - Fee Related DE3584370D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8406660 1984-12-28
PCT/SE1985/000541 WO1986004062A1 (en) 1984-12-28 1985-12-20 Pharmaceutically active compound and a method for its preparation

Publications (1)

Publication Number Publication Date
DE3584370D1 true DE3584370D1 (de) 1991-11-14

Family

ID=20358339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686900345T Expired - Fee Related DE3584370D1 (de) 1984-12-28 1985-12-20 Verwendung von podophyllotoxin und dessen derivaten.

Country Status (23)

Country Link
US (1) US4788216A (de)
EP (1) EP0207124B1 (de)
JP (2) JPH0720966B2 (de)
CN (1) CN1006795B (de)
AP (1) AP32A (de)
AT (1) ATE68186T1 (de)
AU (1) AU585936B2 (de)
CA (1) CA1255230A (de)
DE (1) DE3584370D1 (de)
DK (1) DK169506B1 (de)
DZ (1) DZ876A1 (de)
EG (1) EG17788A (de)
ES (1) ES8701761A1 (de)
FI (1) FI89330C (de)
GR (1) GR853145B (de)
HU (1) HU201672B (de)
IL (1) IL77456A (de)
MA (1) MA20602A1 (de)
NO (1) NO863329D0 (de)
PT (1) PT81760B (de)
TN (1) TNSN86004A1 (de)
WO (1) WO1986004062A1 (de)
ZA (1) ZA859881B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
EP0461141B1 (de) * 1989-02-23 1999-11-03 University Of North Carolina At Chapel Hill Etoposidanaloge
SE464167B (sv) 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5338867A (en) * 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
GB9422947D0 (en) * 1994-11-14 1995-01-04 Univ Salamanca Immunosuppressive cyclolignan derivatives
US6051721A (en) * 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
FI105152B (fi) 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
US6143304A (en) * 1999-08-17 2000-11-07 The University Of Mississippi Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
KR20040030686A (ko) * 2001-06-19 2004-04-09 악셀라르 아베 시클로리그난의 신규의 용도 및 신규의 시클로리그난
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
EP2303261A4 (de) * 2008-06-23 2011-09-07 Axelar Ab Verwendung von cyclolignanen zur behandlung eines überaktiven immunsystems
EP2817007A1 (de) * 2012-02-24 2014-12-31 Nestec S.A. Peltatin zur behandlung chronischer entzündungskrankheiten
WO2015028456A1 (en) * 2013-08-28 2015-03-05 Nestec S.A. PPAR modulators
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA635769A (en) * 1962-01-30 Rutschmann Jurg Amides of podophyllic acid and picropodophyllic acid
SE335139B (de) * 1964-08-12 1971-05-17 Sandoz Ag
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
GB8424269D0 (en) * 1984-09-26 1984-10-31 Pharma Medica As Isolation and purification of podophyllotoxin

Also Published As

Publication number Publication date
JPH07173063A (ja) 1995-07-11
ES8701761A1 (es) 1986-12-01
JP2572558B2 (ja) 1997-01-16
FI89330B (fi) 1993-06-15
GR853145B (de) 1986-04-29
EP0207124A1 (de) 1987-01-07
MA20602A1 (fr) 1986-07-01
IL77456A (en) 1989-07-31
DK408186A (da) 1986-08-27
CN85109666A (zh) 1986-10-29
EG17788A (en) 1990-12-30
TNSN86004A1 (fr) 1990-01-01
DK169506B1 (da) 1994-11-14
US4788216A (en) 1988-11-29
FI863482A (fi) 1986-08-27
NO863329L (no) 1986-08-19
HU201672B (en) 1990-12-28
ES550504A0 (es) 1986-12-01
PT81760A (en) 1986-01-02
WO1986004062A1 (en) 1986-07-17
AU5300386A (en) 1986-07-29
JPH0720966B2 (ja) 1995-03-08
HUT47582A (en) 1989-03-28
NO863329D0 (no) 1986-08-19
IL77456A0 (en) 1986-08-31
ZA859881B (en) 1986-09-24
EP0207124B1 (de) 1991-10-09
PT81760B (pt) 1987-11-11
FI89330C (fi) 1993-09-27
CA1255230A (en) 1989-06-06
ATE68186T1 (de) 1991-10-15
AP32A (en) 1988-12-07
JPS62501360A (ja) 1987-06-04
CN1006795B (zh) 1990-02-14
AU585936B2 (en) 1989-06-29
FI863482A0 (fi) 1986-08-27
AP8500017A0 (en) 1985-11-01
DZ876A1 (fr) 2004-09-13
DK408186D0 (da) 1986-08-27

Similar Documents

Publication Publication Date Title
MX9202933A (es) Derivados de tiazolidindiona.
DK119285A (da) Benzothiazol- og benzothiophenderivater
DE3677206D1 (de) D-luciferin-derivate und deren verwendung.
DE3769122D1 (de) Nitro-derivate von 2-iminoimidazolidinen und 2-iminotetrahydropyrimidinen.
DE3871751T2 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
DE3671434D1 (de) Phenylalaninderivate und proteinaseinhibitor.
DE3584370D1 (de) Verwendung von podophyllotoxin und dessen derivaten.
NO863942L (no) Aminosalter av lignosulfonater.
DE3481307D1 (de) Aglykone und pseudo-aglykone von aad-216-antibiotika.
DE3679896D1 (de) Schmiermittelzusammensetzung und verwendung davon.
DE3688864D1 (de) L-phenylalanindehydrogenase und deren verwendung.
DE3685258D1 (de) Verwendung von pflanzenprotoplasten.
FI853938A0 (fi) Anordning foer profilmaetning av raelshjul.
SE458083B (sv) Elradiator och anvaendning av densamma
DE3583858D1 (de) Derivate von alcoxymethylaether und alcoxymethylester.
ATE125794T1 (de) Prodrogen von antiinflammatorischen 3-acyl-2- oxindol-1-carboxamiden.
DE3675063D1 (de) Mischungen von polycaprolactonpolyolen und polyepoxyden.
DE68917616T2 (de) Demulgator-Zusammensetzungen und Herstellungsmethode und Verwendung.
MX9203229A (es) Derivados de lankacidina.
FI852772A0 (fi) Formsten.
DE3682155D1 (de) Fluessigkristall-alkoxycarbonyloxybenzoesaeurederivate und zusammensetzung.
DE3779211D1 (de) Verwendung von dihydrobenzopyranderivaten.
DE3580092D1 (de) Herstellungsverfahren von 1-bromaethylhydrocarbylcarbonaten und 1-bromaethylhydrocarbylcarbonate.
FI852876A0 (fi) Anordning foer undervattensarbete.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee